Pharmacological manipulations which attenuate the behavioral effects of amphetamine (AMPH) and cocaine (COC) have potential to be important agents for modifying the abuse potential of psychostimulants. The behavioral effects of AMPH are dependent on activation of dopamine (DA) receptors in the striatum and limbic forebrain, and are modulated by the A2 subtype of adenosine receptor. A2 receptors are expressed abundantly and exclusively in forebrain areas enriched in DA receptors. We have recently isolated the rat A2 adenosine receptor cDNA. We are now able to test the hypothesis that modulation of the behavioral effects of AMPH by A2 receptors results from co-activation of A2 and DA receptors residing on a subset of forebrain neurons and subsequent modulation of post-receptor cellular responses in those neurons. Similar cellular mechanisms may underlie the modulatory effects of adenosinergic agents on the behavioral effects of COC. The goals of this grant are to identify the anatomical systems in striatum and limbic forebrain in which A2 and AI adenosine receptors overlap with DA receptors and to determine if modulation of immediate early genes may be a marker of a subset of forebrain neurons in which a functional interaction between adenosine receptors and AMPH occurs. These experiments will begin to identify nuclear mechanisms which underlie the interactions of A2 receptors and psychostimulants.
Three aims are proposed: (1) Determine the localization of A2 receptor mRNA with neurons expressing DA receptor genes and with other neurochemical markers within the striatum and limbic forebrain, (2) Identify the cell types in the striatum and limbic forebrain which express the AI adenosine receptor gene, and (3) Determine whether forebrain A2 adenosine receptors are linked to the same immediate early genes as AMPH. Study of the forebrain A2 adenosine receptor may lead to the identification of anatomical circuits and cellular mechanisms, and novel strategies for their independent regulation, which modulate the rewarding properties of psychostimulants and, more generally, activity of the dopaminergic system in brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA007496-01A1
Application #
3214168
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1992-08-01
Project End
1995-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Chen, Jiang-Fan; Fredduzzi, Silva; Bastia, Elena et al. (2003) Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease. Neurology 61:S74-81
Chen, Jiang-Fan; Moratalla, Rosario; Yu, Liqun et al. (2003) Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacology 28:1086-95
Fredduzzi, Silva; Moratalla, Rosario; Monopoli, Angela et al. (2002) Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. J Neurosci 22:1054-62
Armstrong, J M; Chen, J F; Schwarzschild, M A et al. (2001) Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochem J 354:123-30
Chen, J F; Moratalla, R; Impagnatiello, F et al. (2001) The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci U S A 98:1970-5
Chen, J F; Beilstein, M; Xu, Y H et al. (2000) Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors. Neuroscience 97:195-204
Apasov, S G; Chen, J F; Smith, P T et al. (2000) Study of A(2A) adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A(2A) receptor-unrelated lymphotoxicity. Br J Pharmacol 131:43-50
Chen, J F; Huang, Z; Ma, J et al. (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19:9192-200
Turgeon, S M; Pollack, A E; Fink, J S (1997) Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res 749:120-6
Pollack, A E; Turgeon, S M; Fink, J S (1997) Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. Neuroscience 79:79-93

Showing the most recent 10 out of 17 publications